Nucleobuvir 400mg Tablets — DRAP registration 110535

.home-reveal [data-anim], .home-reveal .hero-title, .home-reveal .section-head, .home-reveal .section-links, .record-reveal .record-kicker, .record-reveal .record-title-block h1, .record-reveal .record-meta > *, .record-reveal .record-index { opacity: 1 !important; } div[hidden][id^="S:"] { display: block !important; } body:has(div[hidden][id^="S:"]) .page-shell { display: none !important; } .loading-note, .skeleton-line, .skeleton-chip, .skeleton-grid { display: none !important; }

Registration details

Registration number: 110535
Registered name: Nucleobuvir 400mg Tablets
Manufacturer: AA Pharma
Category: Essential Drugs
Licence: DSL: 323

Approved price

Regulatory listing from the DRAP price index, not live pharmacy stock or a retail quote.

Pack size	Index price	Effective from
28's	Rs 7,382.54	2025-08-25

What is missing

The DRAP product case file carries the full composition, dosage form, shelf life and marketing-authorisation holder. It could not be fetched, so those are not shown rather than guessed. The DRAP case file may open directly.

Known interactions

DDInter reference list for Sofosbuvir, taken from this pack’s approved price label because the DRAP case file was unavailable. Not a prescription safety check, and absence of a row is not evidence that a combination is safe.

MajorApalutamide
MajorEnzalutamide
MajorLorlatinib
ModerateDicoumarol
ModerateEncorafenib
ModerateFostamatinib
ModerateWarfarin
MinorCyclosporine

Showing 8 of 8. Source: DDInter 2.0, CC BY-NC-SA 4.0. Need a specific pair? Check two medicines.

Made by AA Pharma

5 registrations in the price index are held by this company.

See all 5 AA Pharma registrations →

Checking the DRAP register, the product case file and the price index…